Deutsche Bank Ag\ Travere Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 675,085 shares of TVTX stock, worth $11.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

675,085

Previous 946,601 28.68%

Holding current value

$11.7 Million

Previous $7.78 Million 21.37%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$7.89 - $15.21 $2.14 Million - $4.13 Million	-271,516 Reduced 28.68%	675,085 $9.44 Million
Q2 2024 Aug 14, 2024	SELL	$5.26 - $8.28 $7.65 Million - $12 Million	-1,454,972 Reduced 60.58%	946,601 $7.78 Million
Q1 2024 May 15, 2024	BUY	$7.18 - $9.82 $5,787 - $7,914	806 Added 0.03%	2,401,573 $18.5 Million
Q4 2023 Feb 14, 2024	BUY	$5.44 - $9.5 $11.4 Million - $19.9 Million	2,092,311 Added 678.32%	2,400,767 $21.6 Million
Q3 2023 Nov 09, 2023	SELL	$7.64 - $17.25 $886,889 - $2 Million	-116,085 Reduced 27.34%	308,456 $2.76 Million
Q2 2023 Aug 14, 2023	SELL	$15.3 - $22.61 $799,685 - $1.18 Million	-52,267 Reduced 10.96%	424,541 $6.52 Million
Q1 2023 May 15, 2023	BUY	$17.82 - $22.89 $3.57 Million - $4.59 Million	200,381 Added 72.49%	476,808 $10.7 Million
Q4 2022 Feb 13, 2023	SELL	$18.47 - $26.14 $949,468 - $1.34 Million	-51,406 Reduced 15.68%	276,427 $5.81 Million
Q3 2022 Nov 14, 2022	SELL	$22.91 - $28.63 $4.98 Million - $6.22 Million	-217,401 Reduced 39.87%	327,833 $8.08 Million
Q2 2022 Aug 11, 2022	SELL	$20.94 - $30.01 $603,281 - $864,588	-28,810 Reduced 5.02%	545,234 $13.2 Million
Q1 2022 May 13, 2022	BUY	$23.61 - $30.6 $4.16 Million - $5.4 Million	176,398 Added 44.36%	574,044 $14.8 Million
Q4 2021 Feb 11, 2022	BUY	$24.34 - $31.17 $1.38 Million - $1.77 Million	56,799 Added 16.66%	397,646 $12.3 Million
Q3 2021 Nov 04, 2021	SELL	$12.98 - $25.03 $14,044 - $27,082	-1,082 Reduced 0.32%	340,847 $8.27 Million
Q2 2021 Aug 11, 2021	SELL	$14.11 - $26.4 $1.48 Million - $2.76 Million	-104,640 Reduced 23.43%	341,929 $4.99 Million
Q1 2021 May 13, 2021	BUY	$23.37 - $31.77 $53,470 - $72,689	2,288 Added 0.51%	446,569 $11.2 Million
Q4 2020 Feb 16, 2021	BUY	$19.17 - $27.87 $8.52 Million - $12.4 Million	444,281 New	444,281 $12.1 Million

Others Institutions Holding TVTX

# of Institutions

193

Shares Held

84.6M

Call Options Held

776K

Put Options Held

900K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.12B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account